Baseline mapping of national HTA authorities across the EU and EEA
The EU Health Technology Assessment Regulation (HTAR) has moved from policy to practice, with Joint Clinical Assessments (JCAs) now underway. While clinical assessment is coordinated at the EU level, national HTA authorities and bodies continue to play a central role in appraisal, reimbursement, pricing and patient access decisions. Understanding the current HTA landscape is therefore essential for monitoring how systems adapt and evolve as implementation of the HTAR progresses.
This CIRS R&D Briefing provides a baseline mapping of HTA authorities and bodies across the 27 EU Member States and three European Economic Area (EEA) jurisdictions. The analysis examines agency characteristics, transparency, adaptation to the HTAR, and participation in EU HTA initiatives, providing a snapshot of the current EU HTA landscape.
Key findings
Variation in HTA structures and transparency
HTA bodies across the EU and EEA vary in their establishment year, structure, scope, and levels of publicly available information. The briefing maps differences in agency responsibilities, assessment activities, and the availability of key information such as HTA reports, procedural milestones, and decision rationales.
Evidence of adaptation to the EU HTA Regulation
Evidence of adaptation to the EU HTAR is emerging, with changes to national processes and submission templates identified in a number of jurisdictions. The briefing provides an overview of how HTA authorities and bodies are responding to the introduction of JCAs and related HTAR activities.
Participation in EU HTA activities
The report maps participation as JCA assessors and co-assessors, Joint Scientific Consultation (JSC) assessors and co-assessors, Technical Support Instrument (TSI) activities, and regional HTA collaborations across Europe. These activities provide important context for understanding the increasingly interconnected nature of the European HTA landscape.
About the research
The analysis is based on a structured review of publicly available information from HTA agency websites, national authority websites, procedural documents, and information published by the European Commission’s HTA Coordination Group. The information reflects the status of HTA authorities and bodies up to April 2026.
Many HTA authorities and bodies across Europe reviewed and validated the information included in this briefing, helping to strengthen the accuracy and completeness of the analysis.
This briefing establishes a baseline for monitoring how national HTA systems evolve alongside implementation of the EU HTA Regulation and how these changes may influence future HTA decision making across Europe.
